Only the
European species of the Mistletoe plant is used for cancer treatment.
It can be used to diminish tumor‐related pain and to reduce the risk of tumor recurrence.
Mistletoe (Iscador/Iscar/Helixor) can be used in malignant and non‐malignant tumors, for stimulation of bone marrow activity by increasing the natural killer cells, alongside conventional treatments to offset the side affects of chemotherapy/radiation like nausea, vomiting, and lack of sleep and appetite.
Mistletoe can be prescribed in the United States of America by approved anthroposophic physicians who are trained in complimenting conventional treatment.
Mistletoe is administered intravenously (IV) and subcutaneously (SC), and intratumorly at a frequency determined by the prescribing physician based on your individual needs.
Mistletoe treatments will not cripple or bankrupt a family, as it is only a fraction of the cost of chemotherapy.
Patients can experience fever and local allergic reaction, which are very essential for dose fixing for cancer patient for specific response. Most patients experience a better quality of life as it stimulates the immune system.
In addition to mistletoe, megadoses of IV Vitmain C. Curcumin, Transfer factor, Sodium Bicarbonate Therapy, and Hydrogen peroxide are used in Integrated Oncology.
